These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28267333)

  • 1. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells.
    Lu D; Wang S; Xie Q; Guo L; Wu B
    Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
    Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
    J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.
    Barbier O; Torra IP; Sirvent A; Claudel T; Blanquart C; Duran-Sandoval D; Kuipers F; Kosykh V; Fruchart JC; Staels B
    Gastroenterology; 2003 Jun; 124(7):1926-40. PubMed ID: 12806625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.
    Miyata M; Hata T; Yamakawa H; Kagawa T; Yoshinari K; Yamazoe Y
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):41-7. PubMed ID: 22561792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kininogen gene is transactivated by the farnesoid X receptor.
    Zhao A; Lew JL; Huang L; Yu J; Zhang T; Hrywna Y; Thompson JR; de Pedro N; Blevins RA; Peláez F; Wright SD; Cui J
    J Biol Chem; 2003 Aug; 278(31):28765-70. PubMed ID: 12761213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.
    Wang S; Yuan X; Lu D; Guo L; Wu B
    Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1.
    Hoeke MO; Heegsma J; Hoekstra M; Moshage H; Faber KN
    PLoS One; 2014; 9(2):e88011. PubMed ID: 24498423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
    Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter.
    Shen H; Zhang Y; Ding H; Wang X; Chen L; Jiang H; Shen X
    Cell Physiol Biochem; 2008; 22(1-4):1-14. PubMed ID: 18769028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
    Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
    Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnane X receptor is a target of farnesoid X receptor.
    Jung D; Mangelsdorf DJ; Meyer UA
    J Biol Chem; 2006 Jul; 281(28):19081-91. PubMed ID: 16682417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
    Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
    Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human class I alcohol dehydrogenases by bile acids.
    Langhi C; Pedraz-Cuesta E; Haro D; Marrero PF; Rodríguez JC
    J Lipid Res; 2013 Sep; 54(9):2475-84. PubMed ID: 23772048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
    Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W
    Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
    Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
    PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
    Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
    J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
    Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.